US equities |
MU $931.24 ▲+1.87% NVDA $217.23 ▼-1.84% SNDK $1,394.83 ▼-0.61% AMD $562.23 ▼-1.50% SPCX $148.62 ▼-2.33% INTC $95.37 ▼-2.80% AAPL $342.00 ▼-0.28% MSFT $539.44 ▲+1.08%
FinancialContent

Articles published by Cargo Therapeutics, Inc.

News headline image
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Provides Corporate Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Participate in Upcoming Investor Conferences
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Participate in Upcoming Investor Conferences
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
From Cargo Therapeutics, Inc.
Via GlobeNewswire
Tickers CRGX
News headline image
CARGO Therapeutics Announces Scientific Advisory Board
From Cargo Therapeutics, Inc.
Via GlobeNewswire
News headline image
CARGO Therapeutics Announces Pricing of Initial Public Offering
From Cargo Therapeutics, Inc.
Via GlobeNewswire